SEC Form 4 · accession 0001209191-19-014022
FATE THERAPEUTICS INC · FATE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Cindy Tahl
Officer — General Counsel and Secretary
Period of report
Feb 25, 2019
Accepted (ET)
Feb 27, 2019 · 4:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001434316
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 25, 2019 | M | 25,000 | $2.90 | A | 115,418 | D | |
| Common Stock | Feb 25, 2019 | S | 25,000 | $16.0728 | D | 90,418 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $2.90 | Feb 25, 2019 | M | 25,000 | D | — | Jan 7, 2026 | Common Stock | 25,000 | 98,149 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 20, 2018.
- F2The shares subject to this option shall vest and become exercisable in 48 equal monthly installments beginning on February 8, 2016 such that this option is fully exercisable on January 8, 2020.
- F3Not applicable.